VV

Vishal Vasishth

Investor and Builder of Companies with Inspiring Purpose

San Francisco Bay Area

Invests in

  • Min Investment:

    $500,000.00
  • Max Investment:

    $6,000,000.00
  • Target Investment:

    $3,000,000.00

Work Experience

  • Co-Founder & Managing Director

    2014

    Obvious is a venture capital firm investing in startups reimagining trillion-dollar industries through a world positive lens. Our three investment pillars are Planet Health, Human Health, and Economic Health. We invest at both early and emerging growth stages. Select investments include Beyond Meat, Miyoko's Creamery, and Good Eggs in food; Virta, Devoted Health, and Galileo in healthcare; Zymergen, Recursion Pharmaceuticals, and LabGenius in computational biology; Proterra, Lilium, and Amply in electrified transportation; One Finance, Corvus, and Openly in fintech; and Incredible Health and Gusto, platforms helping people thrive at work.

2024

  • Board Observer

    2024

    Accelerating the development of lifesaving medicines and enabling patients globally to have equal access to the highest quality of cancer care and research

2023

  • Board Member

    2023

    Democratizing the use of cash flow underwriting in our banking system.

  • Board Observer

    2023

    Working to accelerate the impact that transformers and generative AI can have in the healthcare industry.

2022

  • Board Member

    2022

    Branded wallet (debit+credit) for brands.

  • Board Member

    2022

    Building a platform for improving financial lives of working families.

2022

  • Board Member

    2022

    Building a modern fintech platform for healthcare.

  • Board Member

    2024

    Computer vision driven endoscopy for GI disease

  • Board Observer

    2021

    Building a tech enabled full stack healthcare company in the Autism space, with a goal to improve outcomes and reduce cost.

  • Board Observer

    2020

    Building a managed marketplace in the DME healthcare space with a goal to delight all stakeholders, improve outcomes and reduce cost.